A new study published this week in Molecular Psychiatry by Emory University researchers has revealed a promising new avenue ...

Camacho and colleagues’ study highlights the economic and health impacts of high risk non-steroidal anti-inflammatory drug ...

A new study reveals that infliximab, an anti-inflammatory drug, can improve motivation in patients with depression and high ...

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...

It might be time to discard your trusty strip of Paracetamol. The hot-favourite drug option for fever control has alarmingly ...

A recent global study raises questions about the effectiveness of costly, modern migraine medications, revealing that they ...

Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

A meta-analysis reveals triptans as the most effective acute migraine treatments, highlighting the need for their inclusion ...

Sanofi is pursuing several opportunities in MS, a debilitating nerve disease, to offset revenue losses after the recent end ...

A meta-analysis of 137 clinical trials finds triptan drugs are among the most effective for treating migraines, while newer ditan and gepant drugs were rated less highly ...